Effect of 6 Months of Erythromycin Treatment on Inflammatory Cells in Induced Sputum and Exacerbations in Chronic Obstructive Pulmonary Disease - He, Zhi-Yi; Ou, Li-Mei; Zhang, Jian-Quan; Bai, Jing; Liu, Guang-Nan; Li, Mei-Hua; Deng, Jing-Min; MacNee, William; Zhong, Xiao-Ning (Respiration, 2010)
Keywords: Aged; Allergies; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - adverse effects; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Biological and medical sciences; Bones, joints and connective tissue. Antiinflammatory agents; Cells; Chronic obstructive pulmonary disease; Chronic obstructive pulmonary disease, asthma; Clinical Investigations; Double-Blind Method; Drug therapy; Erythromycin - administration & dosage; Erythromycin - adverse effects; Female; Humans; Inflammatory diseases; Leukocyte Count; Leukocyte Elastase - analysis; Male; Medical sciences; Middle Aged; Pharmacology. Drug treatments; Pneumology; Pulmonary Disease, Chronic Obstructive - drug therapy; Pulmonary Disease, Chronic Obstructive - immunology; Quality of Life; Sputum - cytology; Sputum - drug effects; Sputum - immunology; Sputum - microbiology; Treatment Outcome; Exacerbation, respiratory; Chronic obstructive pulmonary disease; Airway inflammation; Anti-inflammatory effects; Macrolides; Neutrophils; Lung disease; Respiratory disease; Antiinflammatory agent; Granulocyte; Inflammation; Erythromycin; Macrolide; Antibiotic; Treatment; Sputum; Bronchus disease; Inflammatory cell; Neutrophil; Antibacterial agent; Pneumology